Table I.
Sequences of primers used for polymerase chain reaction.
Gene | Sequence |
---|---|
Caspase-3 | Forward, 5′-CAAACTTTTTCAGAGGGGATCG-3′ |
Reverse, 5′-GCATACTGTTTCAGCATGGCA-3′ | |
Caspase-8 | Forward, 5′-CCCCACCCTCACTTTGCT-3′ |
Reverse, 5′-GGAGGACCAGGCTCACTTA-3′ | |
Caspase-9 | Forward, 5′-GGCCCTTCCTCGCTTCATCTC-3′ |
Reverse, 5′-GGTCCTTGGGCCTTCCTGGTAT-3′ | |
Bax | Forward, 5′-AAGCTGAGCGAGTGTCTCCGGCG-3′ |
Reverse, 5′-CAGATGCCGGTTCAGGTACTCAGTC-3′ | |
Bcl-2 | Forward, 5′-CTCGTCGCTACCGTCGTGACTTGG-3′ |
Reverse, 5′-CAGATGCCGGTTCAGGTACTCAGTC-3′ | |
Bcl-xL | Forward, 5′-CCCAGAAAGGATACAGCTGG-3′ |
Reverse, 5′-GCGATCCGACTCACCAATAC-3′ | |
Fas | Forward, 5′-GAAATGAAATCCAAAGCT-3′ |
Reverse, 5′-TAATTTAGAGGCAAAGTGGC-3′ | |
FasL | Forward, 5′-GGATTGGGCCTGGGGATGTTTCA-3′ |
Reverse, 5′-TTGTGGCTCAGGGGCAGGTTGTTG-3′ | |
p53 | Forward, 5′-GCTCTGACTGTACCACCATCC-3′ |
Reverse, 5′-CTCTCGGAACATCTCGAAGCG-3′ | |
p21 | Forward, 5′-CTCAGAGGAGGCGCCATG-3′ |
Reverse, 5′-GGGCGGATTAGGGCTTCC-3′ | |
hIAP-1 | Reverse, 5′-GCCTGATGCTGGATAACTGG-3′ |
Forward, 5′-GGCGACAGAAAAGTCAATGG-3′ | |
hIAP-2 | Reverse, 5′-GCCTGATGCTGGATAACTGG-3′ |
Forward, 5′-GCTCTTGCCAATTCTGATGG-3′ | |
NF-κB | Forward, 5′-CACTTATGGACAACTATGAGGTCTCTGG-3′ |
Reverse, 5′-CTGTCTTGTGGACAACGCAGTGGAATTTTAGG-3′ | |
IκB-α | Forward, 5′-GCTGAAGAAGGAGCGGCTACT-3′ |
Reverse, 5′-TCGTACTCCTCGTCTTTCATGGA-3′ | |
COX-2 | Reverse, 5′-TTAAAATGAGATTGTCCGAA-3′ |
Forward, 5′-AGATCACCTCTGCCTGAGTA-3′ | |
iNOS | Reverse, 5′-AGAGAGATCGGGTTCACA-3′ |
Forward, 5′-CACAGAACTGAGGGTACA-3′ | |
GAPDH | Reverse, 5′-CGGAGTCAACGGATTTGGTC-3′ |
Forward, 5′-AGCCTTCTCCATGGTCGTGA-3′ |
Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; Bcl-xL, Bcl-extra large protein; FasL, Fas ligand; hIAP, human inhibitor of apoptosis; NF-κB, nuclear factor-κB; I-κB-α, inhibitor of NF-κB α; COX, cyclooxygenase; iNOS, inducible nitric oxide synthase.